Vireo Growth (VREOF) Net Margin (2020 - 2026)
Vireo Growth (VREOF) posted Net Margin of 21.19% for Q1 2026, up 34.45% sequentially from 32.32% in Q4 2025, and down 4102.0% YoY from 0.53% in Q1 2025.
Vireo Growth (VREOF) Net Margin (2020 - 2026) Analysis & Trends
Vireo Growth has reported Net Margin for 7 years, with the latest figure at 21.19% in Q1 2026.
- Quarterly Net Margin fell 4102.0% year-over-year to 21.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.22% (down 3178.0% YoY) and the FY2025 annual result came in at 30.33%, down 4679.0% from the prior year.
- Net Margin advanced to 21.19% in Q1 2026 per VREOF's latest filing, from 32.32% in the prior quarter.
- Over five years, Net Margin peaked at 19.84% in Q1 2025 and troughed at 113.07% in Q1 2022.
- A 5-year average of 16.95% and a median of 21.19% in 2026 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2023: Net Margin plunged 5914 bps in 2022, then surged 6870 bps in 2023.
- Over 5 years, Net Margin stood at 48.79% in 2022, then soared by 130 bps to 14.77% in 2023, then grew by 14 bps to 16.81% in 2024, then sank by 292 bps to 32.32% in 2025, then jumped by 34 bps to 21.19% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 21.19%, 32.32%, and 3.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Vireo Growth | 492.35 Mn | 350.05 Mn | 95.30 Mn | -2.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.19% |
| Dec 31, 2025 | -32.32% |
| Sep 30, 2025 | 3.01% |
| Jun 30, 2025 | 7.64% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.81% |
| Sep 30, 2024 | 17.47% |
| Jun 30, 2024 | 16.16% |
| Mar 31, 2024 | 15.36% |
| Dec 31, 2023 | 14.77% |
| Sep 30, 2023 | -23.22% |
| Jun 30, 2023 | -36.59% |
| Mar 31, 2023 | -44.37% |
| Dec 31, 2022 | -48.79% |
| Sep 30, 2022 | -50.78% |
| Jun 30, 2022 | -28.94% |
| Mar 31, 2022 | -113.07% |
| Dec 31, 2021 | -103.17% |
| Sep 30, 2021 | -51.16% |
| Jun 30, 2021 | -49.10% |